List view / Grid view
13 May 2015 | By Victoria White
Results from a Phase 3 study of the liquid-frozen formulation of IMVAMUNE support a Biologics License Application for US approval of the vaccine...
13 May 2015 | By Victoria White
CPhI Worldwide has launched a new partnership with charity Global Angels to help promote its efforts and encourage support from the pharmaceutical industry....
13 May 2015 | By
Actavis has responded to the decision by the SMC to accept Ozurdex for use by NHS Scotland for the treatment of visual impairment in patients with DMO...
Baxter has signed a definitive agreement to acquire the Oncaspar® (pegaspargase) product portfolio from Sigma-Tau for US $900 million.
12 May 2015 | By Victoria White
Highland Therapeutics has announced that it will host a poster presentation highlighting Phase III clinical data for its ADHD treatment at APA 2015...
12 May 2015 | By Victoria White
GBI Research reports on the highly diverse and innovative pipeline for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy treatment...
12 May 2015 | By Klyo Collaborative
Seven companies have voluntarily come together to form a new collaborative problem-solving group, aimed at assisting biopharmaceutical companies solve their most pressing lifecycle pipeline problems...
12 May 2015 | By Victoria White
The FDA has granted Fast Track designation for the development of evofosfamide for the treatment of patients with advanced pancreatic cancer...
12 May 2015 | By Penn Pharma
Pharmaceutical manufacturer Penn Pharma a PCI company, today announced the successful installation of the Gerteis Mini-Pactor at its contained manufacturing facility...
12 May 2015 | By Victoria White
CPhI Istanbul (#cphiIstanbul), organised by UBM EMEA, will return to ICC Istanbul Congress Center, Istanbul, Turkey from 3 to 5 June 2015...
12 May 2015 | By Victoria White
Inovio Pharmaceuticals has initiated a Phase I trial to evaluate safety, tolerability and immune responses of its Ebola DNA immunotherapy...
12 May 2015 | By Victoria White
Takeda has announced that the first patient has been enrolled in the Phase 3 TOURMALINE-MM4 study of investigational oral ixazomib...
12 May 2015 | By Victoria White
The number of strokes occurring in men aged between 40 and 54 has rocketed by almost 50% in less than 15 years, according to the Stroke Association...
12 May 2015 | By Victoria White
GW Pharmaceuticals has commenced a Phase 3 clinical trial of Epidiolex (cannabidiol or CBD) for the treatment of Lennox-Gastaut syndrome (LGS)...
12 May 2015 | By Victoria White
Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company...
